Epitalon vs Thymogen
Well Studied vs Well Studied
synergistic Combination showed significant lifespan increases and robust antitumor activity in research.
Molecular Data
Epitalon Thymogen
Weight 390.35 Da 333 Da
Half-life Not established (short peptide) Not established
Chain 4 amino acids 2 amino acids
Type Tetrapeptide Dipeptide bioregulator
Key Benefits
Epitalon
01 Telomere extension and cellular replicative lifespan extension
02 Enhanced melatonin production
03 Improved immune function
04 Potential lifespan extension (25-33% in animal studies)
05 Systemic anti-aging through cellular rejuvenation
06 Short cycle duration with long-lasting effects
Thymogen
01 Modulates humoral and cellular immunity
02 Activates T-cell differentiation
03 Normalizes T-lymphocyte populations (CD3+, CD4+, CD8+)
04 Stimulates immunoglobulin production
05 Enhances regeneration and cellular metabolism
06 Demonstrated geroprotective (anti-aging) activity
07 Antitumor activity in research models
08 Registered pharmaceutical in Russia
09 Multiple delivery forms available
Dosing Protocols
Epitalon
100-500mcg per injection / Once daily for 10-20 consecutive days
Standard anti-aging 200-500mcg 1x daily for 10-20 days
Conservative start 100mcg 1x daily for 10-20 days
Russian clinical equivalent 300mcg 1x daily for 10-20 days
Ultra-low dose 50mcg 1x daily for 10-20 days
Thymogen
10-20mg daily during cycle / Daily for 10-20 days, then break
Standard immune support 10-20 mg Daily for 10-20 days
Maintenance protocol 20 mg 2-3 cycles per year
Side Effects
Epitalon
Generally well-tolerated with minimal side effects
Mild injection site reactions
Vivid dreams (melatonin-related)
Possible mild digestive upset (oral route)
Thymogen
Generally well-tolerated
Injection site reactions (mild)
Minimal side effects reported in clinical use
Contraindications
Active malignancy (telomerase activation concern)
Chronic sinusitis (nasal route)
Known peptide allergies
Pregnancy or breastfeeding
Active autoimmune diseases (use with caution)
Organ transplant recipients on immunosuppression
Known hypersensitivity to component amino acids
Pregnancy or breastfeeding
Research Evidence
Epitalon Thymogen
Status Well Studied Well Studied
References 6 studies 4 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.